8-K/ALeadership ChangesShareholder MattersOther Events

CARDINAL HEALTH INC 8-K/A Report, Executive Changes (Nov 9, 2015)

Filed November 9, 2015For Securities:CAH

Summary

This 8-K/A filing from Cardinal Health Inc. (CAH) on November 9, 2015, primarily reports on the outcomes of its 2015 Annual Meeting of Shareholders held on November 4, 2015. Key governance and shareholder voting results are detailed, including the election of directors, ratification of independent auditors, and advisory approval of executive compensation. Additionally, the filing provides an updated description of Cardinal Health's capital stock, clarifying the authorized shares, rights of common shareholders, and the potential implications of preferred stock issuance. It also outlines certain anti-takeover provisions under Ohio law and an exclusive forum provision for legal actions, which are important considerations for investors regarding corporate governance and potential strategic actions. The appointment of Nancy Killefer to the Human Resources and Compensation Committee further solidifies the board's structure. The overwhelming shareholder support for the nominated directors, the independent auditor, and executive compensation suggests general confidence in the company's current leadership and practices. Investors should note the details regarding authorized share capital and the mechanisms for potential future issuances, as well as the protective measures in place that could influence future corporate control scenarios.

Key Highlights

  • 1Shareholders overwhelmingly elected all 11 director nominees to the Board of Directors.
  • 2Ernst & Young LLP was ratified as the independent auditor for the fiscal year ending June 30, 2016, with strong shareholder approval.
  • 3Shareholders provided advisory approval for the compensation of Cardinal Health's named executive officers.
  • 4Nancy Killefer was appointed to the Human Resources and Compensation Committee of the Board.
  • 5The filing provides an updated and superseding description of Cardinal Health's capital stock, including details on authorized common and preferred shares and shareholder rights.
  • 6Cardinal Health's authorized common shares total 750,000,000, with approximately 329 million issued and outstanding as of September 30, 2015.
  • 7The report outlines Ohio's Chapter 1704 anti-takeover provisions, which restrict business combinations with "interested shareholders" for a period of three years.

Frequently Asked Questions

The key outcomes were the election of all 11 director nominees, the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2016, and advisory approval of executive compensation. Additionally, Nancy Killefer was appointed to the Human Resources and Compensation Committee.

The filing supersedes previous descriptions of capital stock. It states that Cardinal Health is authorized to issue up to 750,000,000 common shares, with approximately 329 million issued and outstanding as of September 30, 2015. It also details the rights of common shareholders, including voting rights and dividend participation, and notes the potential for issuing preferred shares which could impact common shareholders and a change of control.

Yes, the filing summarizes Chapter 1704 of the Ohio Revised Code, which imposes restrictions on "interested shareholders" (those owning 10% or more of voting stock) engaging in certain business combinations with the company for a three-year period, unless specific conditions are met or prior board approval was granted.

Cardinal Health's regulations specify that a state court in Franklin County, Ohio (or the federal court if no state court has jurisdiction) will be the exclusive forum for derivative suits and certain other actions against the company, its directors, officers, or employees related to Ohio corporation law, the Articles, or Regulations, unless the company consents to an alternate forum.